BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
37.07
+0.69 (1.90%)
Aug 31, 2026, 4:00 PM EDT - Market closed
BioLife Solutions Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 106.69 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 |
Revenue Growth | 30.12% | 28.89% | 9.75% | -10.79% | -36.02% | 147.79% |
Gross Profit Gross Profit Growth | 67.87 | 62.12 | 50.1 | 41.32 | 46.91 | 38.18 |
Operating Income Operating Income Growth | 1.75 | -1.08 | -4.48 | -19.4 | -10.68 | -29.52 |
Net Income Net Income Growth | 57.98 | -4.6 | -20.18 | -68 | -139.81 | -8.91 |
Earnings Per Share EPS Growth | 1.16 | -0.10 | -0.44 | -1.56 | -3.29 | -0.23 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 83.53 | 76.97 | 55.99 | 55.09 | 62.52 | 101.28 |
Europe, Middle East, Africa (EMEA) Europe, Middle East, Africa (EMEA) Growth | 16.3 | 13.47 | 14.18 | 8.16 | 9.15 | 13.11 |
Other Other Growth | 6.86 | 5.77 | 4.48 | 4.76 | 4.57 | 4.77 |
Total Total Growth | 106.69 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 113.07 | 120.18 | 105.36 | 44.73 | 62.7 | 69.86 |
Total Debt Total Debt Growth | 15.74 | 17.9 | 30.04 | 33.83 | 43.71 | 26.88 |
Net Cash (Debt) Net Cash Growth | 97.33 | 102.28 | 75.32 | 10.91 | 18.99 | 42.98 |
Net Cash Growth | 27.36% | 35.79% | 590.69% | -42.57% | -55.82% | -45.77% |
Net Cash Per Share Net Cash Per Share Growth | 1.96 | 2.10 | 1.64 | 0.25 | 0.44 | 1.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 16.88 | 20.12 | 8.43 | -12.5 | -8.49 | -4.59 |
Capital Expenditures CapEx Growth | -9.24 | -10.36 | -5.3 | -11.24 | -13.92 | -14.76 |
Free Cash Flow Free Cash Flow Growth | 7.63 | 9.75 | 3.14 | -23.74 | -22.41 | -19.35 |
Free Cash Flow Growth | -29.73% | 210.94% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.61% | 64.56% | 67.11% | 60.75% | 61.53% | 32.04% |
Operating Margin | 1.64% | -1.12% | -6.00% | -28.52% | -14.01% | -24.77% |
Pretax Margin | 6.40% | -12.56% | -11.82% | -17.97% | -6.36% | -24.36% |
Profit Margin | 54.35% | -4.78% | -27.04% | -99.98% | -183.38% | -7.48% |
FCF Margin | 7.16% | 10.13% | 4.20% | -34.90% | -29.39% | -16.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 129.30 | 299.08 | 223.59 | 223.59 | 223.59 | 223.59 |
P/FCF Ratio | 237.52 | 119.40 | 384.00 | - | - | - |
PS Ratio | 16.99 | 12.10 | 16.13 | 10.76 | 10.21 | 13.03 |